Literature DB >> 7095367

Mechanism of increase in steatorrhea with calcium and magnesium in exocrine pancreatic insufficiency: an animal model.

D Y Graham, J W Sackman.   

Abstract

We used a rat model to investigate the phenomenon of increased steatorrhea associated with administration of calcium or magnesium containing antacids in humans with pancreatic insufficiency. Adult male rats with bile and pancreatic duct ligation were fed test meals containing 56 mumol [14C]triolein (0.5 ml), synthetic human bile (1.0 ml, 100 mumol bile salts, 75% glycine and 25% taurine conjugates, and 14.5 mumol lecithin), pancreatic enzymes (0.5 ml), and antacids (1.0 ml). The percent lipid malabsorbed when antacids were fed in addition to the test meal was: control 19.3 +/- 1%, NaHCO3 15.3 +/- 1% (P less than 0.05 vs. control), Al(OH)3 18.3 +/- 2%, Mg(OH)2 38.2 +/- 2% (p less than 0.001 vs. control), and CaCO3 42.4 +/- 1% (p less than 0.001 vs control). With NaCl, Al(OH)3, and NaHCO3 the malabsorbed fat was primarily triolein, whereas with Ca++ or Mg++ the majority of the lipid recovered was oleic acid. Calcium or magnesium administration was associated with precipitation of glycine-, but not taurine-, conjugated bile salts in the small intestine. When calcium was administered to animals in which the bile consisted entirely of glycine-conjugated bile salts, the lipid recovered (64.0 +/- 3% malabsorption) was almost entirely triolein suggesting reduced lipolysis. These studies suggest that these divalent cations exert their deleterious effect on replacement enzyme therapy by formation of poorly soluble calcium or magnesium soaps and precipitation of glycine conjugated bile salts.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7095367

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  Intestinal milk-bolus obstruction in premature infants.

Authors:  B Koletzko
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

2.  Solubility of calcium soaps of long-chain fatty acids in simulated intestinal environment.

Authors:  D Y Graham; J W Sackman
Journal:  Dig Dis Sci       Date:  1983-08       Impact factor: 3.199

Review 3.  Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use.

Authors:  P N Maton; M E Burton
Journal:  Drugs       Date:  1999-06       Impact factor: 9.546

4.  In vitro adsorption of bile salts and aspirin to sucralfate.

Authors:  D Y Graham; J W Sackman; D H Giesing; D J Runser
Journal:  Dig Dis Sci       Date:  1984-05       Impact factor: 3.199

Review 5.  Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21(st) century.

Authors:  Tony Trang; Johanna Chan; David Y Graham
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 6.  Exocrine pancreatic insufficiency in adults: a shared position statement of the Italian Association for the Study of the Pancreas.

Authors:  Raffaele Pezzilli; Angelo Andriulli; Claudio Bassi; Gianpaolo Balzano; Maurizio Cantore; Gianfranco Delle Fave; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

7.  Absorption of isomeric, palmitic acid-containing triacylglycerols resembling human milk fat in the adult rat.

Authors:  N J de Fouw; G A Kivits; P T Quinlan; W G van Nielen
Journal:  Lipids       Date:  1994-11       Impact factor: 1.880

Review 8.  Rational Use of Pancreatic Enzymes for Pancreatic Insufficiency and Pancreatic Pain.

Authors:  Gyanprakash A Ketwaroo; David Y Graham
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

9.  Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis.

Authors:  Devi Mukkai Krishnamurty; Atoosa Rabiee; Sanjay B Jagannath; Dana K Andersen
Journal:  Ther Clin Risk Manag       Date:  2009-07-12       Impact factor: 2.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.